TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to provide an update on its ongoing fall evaluation program at the Black Raven ...
Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Accurately quantifying specific proteins from complex mixtures like cell lysates, for ...
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a diagnostics technology company, today announced additional favorable data regarding its lead assay VitaGraft™, which ...
C. pneumoniae is a zoonotic pathogen that can cause respiratory diseases, including pneumonia, bronchitis, and pharyngitis, as well as chronic obstructive pulmonary disease and cardiovascular ...
A complement C4 (also known as a complement component 4, or simply C4) is a test to measure the level of C4 proteins you have in your blood. These proteins play a role in how your immune system ...
In recent decades, rapid progression of monoclonal antibody (mAb) development has culminated in approvals for more than one hundred therapeutics in the United States. mAbs enhance the immune response ...
Research and development of monoclonal antibody (mAb) therapeutics is a vast and expanding area of drug discovery, largely due to mAb potential for high specificity and affinity towards target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback